"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente-South San Francisco conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 92 clinical trials were completed, i.e. on average, 89.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 50 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-South San Francisco" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "SWOG Cancer Research Network" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "NSABP Foundation Inc" with 13 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-South San Francisco" #1 collaborator was "National Cancer Institute (NCI)" with 116 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-South San Francisco" are "Breast Cancer" (22 trials), "Colorectal Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Kaiser Permanente-South San Francisco" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-South San Francisco" are "Drug" (154 trials), "Other" (108 trials), "Biological" (68 trials), "Procedure" (42 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (56 trials), "Quality-of-Life Assessment" (46 trials), "Questionnaire Administration" (26 trials), "Carboplatin" (24 trials) and "Paclitaxel" (23 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-South San Francisco" are 141 trials for "All" genders, 47 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-South San Francisco". undefined are not yet recruiting, 33 are recruiting, 87 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Kaiser Permanente-South San Francisco, 4 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-South San Francisco, 4 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".